Amphastar Pharmaceuticals, Inc.AMPHNASDAQ
Loading
Price to Sales: Discounted ValuationCompressed
Percentile Rank21
3Y CAGR-13.9%
5Y CAGR-8.5%
Year-over-Year Change
Price-to-sales ratio
3Y CAGR
-13.9%/yr
vs -3.4%/yr prior
5Y CAGR
-8.5%/yr
Recent deceleration
Acceleration
-10.5pp
Decelerating
Percentile
P21
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
2 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 1.74 | -29.2% |
| 2024 | 2.46 | -47.0% |
| 2023 | 4.63 | +69.9% |
| 2022 | 2.73 | +7.3% |
| 2021 | 2.54 | -6.0% |
| 2020 | 2.70 | -3.8% |
| 2019 | 2.81 | -10.3% |
| 2018 | 3.13 | -15.2% |
| 2017 | 3.69 | +12.8% |
| 2016 | 3.28 | - |